Has Walter Boomer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $42,695 in general payments to Walter Boomer, MD across 1,072 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Walter Boomer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Walter Boomer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Walter Boomer, MD

Pulmonary Disease · Tulsa, OKNPI 1578598074

Payments from drug & device makers

$42,695in general payments, 2019–2025

Across 1,072 payments — averaging $39.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$20K
Pulmonx Corporation$4K
AstraZeneca$3K
GSK$2K
Boehringer Ingelheim$2K
Grifols USA, LLC$1K
plus $10K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	74	$20,096
Pulmonx Corporation	78	$3,948
AstraZeneca	165	$3,409
GSK	167	$2,288
Boehringer Ingelheim	107	$2,218
Grifols USA, LLC	64	$1,083
Vapotherm Inc	11	$842
United Therapeutics Corporation	31	$726
Actelion Pharmaceuticals US, Inc.	25	$654
Mylan Specialty L.p.	22	$643
Sanofi	31	$626
Sunovion Pharmaceuticals Inc.	47	$470
Baxter Healthcare	23	$464
Alkermes, Inc.	21	$408
Genentech USA, Inc.	22	$402
Veran Medical Technologies, Inc.	3	$398
Mallinckrodt Hospital Products Inc.	13	$372
Regeneron Healthcare Solutions, Inc.	16	$356
Takeda Pharmaceuticals U.S.A., Inc.	16	$317
AbbVie(2 entities)	10	$284
Insmed, Inc.	15	$263
Verona Pharma, Inc.	15	$232
Amgen	8	$153
Siemens Medical Solutions USA, Inc.	1	$150
Teva Pharmaceuticals USA, Inc.	9	$145
Galvanize Therapeutics, Inc	1	$138
Medtronic	1	$125
Davol Inc.	1	$123
Electromed, Inc.	9	$122
Merck	6	$112
Novo Nordisk	5	$107
Johnson & Johnson(2 entities)	6	$106
Boston Scientific	1	$105
Inogen, Inc.	9	$98
Advanced Respiratory, Inc	4	$91
Philips North America LLC	4	$75
Gilead	4	$73
Viatris Specialty LLC	3	$63
Circassia Inc.	5	$62
Bayer	2	$42
Fujifilm Healthcare Americas Corporation	1	$35
Covis Pharma GmbH	2	$34
ANI Pharmaceuticals, Inc.	2	$33
Inspire Medical Systems, Inc.	1	$31
Inari Medical, Inc.	2	$30
Vifor Pharma, Inc.	1	$25
Novartis	1	$22
Ambu Inc.	1	$19
Hikma Pharmaceuticals USA	1	$18
Shire North American Group Inc	1	$17
Paratek Pharmaceuticals, Inc.	1	$15
Olympus America Inc.	1	$14
BTG International Inc.	2	$14

How this compares

$42,695 in reported general payments places this provider in the 85th percentile of 133 pulmonary disease providers in Oklahoma.

See all pulmonary disease providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$152,704

Medicare patients

686

Services billed

1,444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Tulsa

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →